本文翻译正在准备中。在此之前，我们暂时显示英文原文。
商业 · 2026/2/201 分钟阅读
Prospective Grant of an Exclusive Patent License: In Vivo Manufactured Anti-CD19 Chimeric Antigen Receptor (CAR) Products for the Treatment or Prevention of B Cell Mediated Autoimmune Diseases
本地自动翻译 · 来源原始语言
摘要
The Department of Health and Human Services, National Institutes of Health published a Notice in the Federal Register on August 5, 2025. That notice requires a correction in the SUPPLEMENTARY INFORMATION section.
来源原始语言: Federal Register — Health and Human Services打开原始公告 →